172 related articles for article (PubMed ID: 17707537)
1. The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.
Söderlund K; Skoog L; Fornander T; Askmalm MS
Radiother Oncol; 2007 Sep; 84(3):242-51. PubMed ID: 17707537
[TBL] [Abstract][Full Text] [Related]
2. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.
Brekelmans CT; Tilanus-Linthorst MM; Seynaeve C; vd Ouweland A; Menke-Pluymers MB; Bartels CC; Kriege M; van Geel AN; Burger CW; Eggermont AM; Meijers-Heijboer H; Klijn JG
Eur J Cancer; 2007 Mar; 43(5):867-76. PubMed ID: 17307353
[TBL] [Abstract][Full Text] [Related]
3. DNA repair gene expression and risk of locoregional relapse in breast cancer patients.
Le Scodan R; Cizeron-Clairac G; Fourme E; Meseure D; Vacher S; Spyratos F; de la Lande B; Cvitkovic F; Lidereau R; Bieche I
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):328-36. PubMed ID: 20092964
[TBL] [Abstract][Full Text] [Related]
4. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
Chen JJ; Silver D; Cantor S; Livingston DM; Scully R
Cancer Res; 1999 Apr; 59(7 Suppl):1752s-1756s. PubMed ID: 10197592
[TBL] [Abstract][Full Text] [Related]
5. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
[TBL] [Abstract][Full Text] [Related]
6. Variation in the RAD51 gene and familial breast cancer.
Lose F; Lovelock P; Chenevix-Trench G; Mann GJ; Pupo GM; Spurdle AB;
Breast Cancer Res; 2006; 8(3):R26. PubMed ID: 16762046
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
Cousineau I; Abaji C; Belmaaza A
Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
[TBL] [Abstract][Full Text] [Related]
8. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.
Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Cancer Detect Prev; 2008; 32(2):144-8. PubMed ID: 18632222
[TBL] [Abstract][Full Text] [Related]
10. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of HuR in hereditary breast cancer.
Heinonen M; Fagerholm R; Aaltonen K; Kilpivaara O; Aittomäki K; Blomqvist C; Heikkilä P; Haglund C; Nevanlinna H; Ristimäki A
Clin Cancer Res; 2007 Dec; 13(23):6959-63. PubMed ID: 18056170
[TBL] [Abstract][Full Text] [Related]
12. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
Aaltonen K; Blomqvist C; Amini RM; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H
Clin Cancer Res; 2008 Apr; 14(7):1976-83. PubMed ID: 18381935
[TBL] [Abstract][Full Text] [Related]
13. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.
Ding SL; Yu JC; Chen ST; Hsu GC; Kuo SJ; Lin YH; Wu PE; Shen CY
Carcinogenesis; 2009 Jan; 30(1):43-9. PubMed ID: 18974064
[TBL] [Abstract][Full Text] [Related]
15. A specific RAD51 haplotype increases breast cancer risk in Jewish non-Ashkenazi high-risk women.
Gal I; Kimmel G; Gershoni-Baruch R; Papa MZ; Dagan E; Shamir R; Friedman E
Eur J Cancer; 2006 May; 42(8):1129-34. PubMed ID: 16624550
[TBL] [Abstract][Full Text] [Related]
16. Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer.
Romanowicz-Makowska H; Smolarz B; Kulig A
Pol J Pathol; 2005; 56(4):161-5. PubMed ID: 16477874
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.
Waltersson MA; Askmalm MS; Nordenskjöld B; Fornander T; Skoog L; Stål O
Int J Oncol; 2009 Feb; 34(2):441-8. PubMed ID: 19148479
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
19. Identification of Rad51 alteration in patients with bilateral breast cancer.
Kato M; Yano K; Matsuo F; Saito H; Katagiri T; Kurumizaka H; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nagawa H; Nakamura Y; Miki Y
J Hum Genet; 2000; 45(3):133-7. PubMed ID: 10807537
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Li WF; Hu Z; Rao NY; Song CG; Zhang B; Cao MZ; Su FX; Wang YS; He PQ; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Liu XY; Zhou J; Wang L; Zhao L; Liu YB; Yuan WT; Yang L; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2008 Jul; 110(1):99-109. PubMed ID: 17851763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
